Mitochondrial Calcium Dysregulation During Perioperative Organ Injury: Mechanisms, Clinical Relevance, and Emerging Therapeutic Perspectives

Abstract

Mitochondrial calcium homeostasis is fundamental to cellular energy production, redox regulation, and cell survival. Perioperative organ injury, commonly encountered during major surgical procedures, is increasingly recognized to involve mitochondrial calcium dysregulation as a central pathomechanism. This review synthesizes recent evidence on the mechanistic links between perioperative stress, mitochondrial calcium overload, and subsequent organ dysfunction. We explore epidemiological trends, pathophysiological underpinnings, clinical manifestations, diagnostic strategies, and current as well as emerging management approaches. The review emphasizes integrating mechanistic insights into clinical practice, discusses risk stratification, and outlines guideline recommendations for optimizing perioperative outcomes in at-risk populations.

Introduction

Perioperative organ injury remains a significant cause of morbidity and mortality in surgical patients despite advances in anesthesia, surgical techniques, and perioperative care. Organ systems most frequently affected include the heart (myocardial injury), kidneys (acute kidney injury), liver, and lungs. The pathogenesis of perioperative organ injury is complex and multifactorial, implicating ischemia-reperfusion, inflammatory cascades, oxidative stress, and metabolic disturbances. Recent research highlights mitochondrial dysfunction—specifically, dysregulation of mitochondrial calcium handling—as a critical mediator linking perioperative insults to cellular injury and organ failure. Understanding these mechanisms is essential for risk stratification, prevention, and the development of targeted therapies in the perioperative setting.

Epidemiology / Disease Burden

Perioperative organ injury is prevalent among patients undergoing major surgeries, with incidence rates for acute kidney injury (AKI) ranging from 5% to 30% depending on procedure type and patient comorbidities. Myocardial injury after non-cardiac surgery (MINS) occurs in up to 20% of high-risk patients. These complications are independently associated with increased length of hospitalization, healthcare costs, and reduced long-term survival. The burden is particularly pronounced in elderly patients, those with pre-existing organ dysfunction, and individuals undergoing emergency or high-risk procedures. As surgical populations age and the complexity of interventions increases, the clinical impact of perioperative organ injury continues to rise, underscoring the need for improved mechanistic understanding and preventive strategies.

Pathophysiology

Mitochondria are central regulators of cellular metabolism and energy production. Calcium ions (Ca²⁺) play a pivotal role in modulating mitochondrial bioenergetics, with tightly controlled uptake via the mitochondrial calcium uniporter (MCU) complex. During perioperative stress—particularly ischemia-reperfusion—excessive cytosolic Ca²⁺ influx leads to mitochondrial Ca²⁺ overload. This triggers opening of the mitochondrial permeability transition pore (mPTP), loss of membrane potential, ATP depletion, and release of pro-apoptotic factors. Additionally, heightened mitochondrial Ca²⁺ amplifies reactive oxygen species (ROS) generation, exacerbating oxidative damage and inflammatory signaling. These events culminate in cell death and organ dysfunction. Animal and human studies consistently demonstrate that interventions attenuating mitochondrial Ca²⁺ uptake or stabilizing mitochondrial dynamics confer protection against perioperative organ injury.

Risk Factors

Risk factors for perioperative mitochondrial calcium dysregulation and resultant organ injury include advanced age, pre-existing cardiovascular or renal disease, diabetes mellitus, and systemic inflammatory states. Procedural factors such as prolonged surgery, significant blood loss, hypotension, and exposure to nephrotoxic or cardiotoxic agents further increase susceptibility. Genetic polymorphisms affecting mitochondrial function, as well as pharmacologic agents that impair mitochondrial calcium handling, may also predispose certain patients. Comprehensive perioperative risk assessment—including evaluation of comorbidities, surgical complexity, and medication profiles—is essential for early identification of vulnerable individuals.

Clinical Features

Perioperative organ injury manifests variably depending on the affected organ system. Myocardial injury is often clinically silent but may present with arrhythmias, hypotension, or heart failure. AKI is characterized by rising serum creatinine and reduced urine output, sometimes progressing to overt renal failure. Hepatic injury may be evidenced by transaminase elevation and coagulopathy, while pulmonary injury manifests as hypoxemia or acute respiratory distress. These clinical features often overlap and may be subtle in the immediate postoperative period, necessitating a high index of suspicion and objective monitoring for timely recognition and intervention.

Diagnosis

Diagnosis of perioperative organ injury relies on a combination of clinical assessment, laboratory biomarkers, and advanced imaging. Cardiac troponins, natriuretic peptides, and electrocardiography are standard for detecting myocardial injury. Kidney injury is identified through serial serum creatinine measurements and urine output monitoring. Liver function tests and coagulation profiles aid in detecting hepatic dysfunction. Emerging biomarkers, such as circulating mitochondrial DNA or novel proteins involved in mitochondrial stress, are under investigation for early detection and risk stratification. Noninvasive imaging modalities—including echocardiography, renal Doppler, and functional MRI—provide additional organ-specific information. Integration of clinical, biochemical, and imaging data supports accurate diagnosis and guides management.

Treatment & Management

Management of perioperative organ injury is multifaceted, encompassing preventive, supportive, and targeted strategies. Optimization of hemodynamics, avoidance of hypoxia and hypotension, and minimization of perioperative insults are foundational. Pharmacologic interventions targeting mitochondrial calcium handling—such as MCU inhibitors, mPTP blockers (e.g., cyclosporine A), and antioxidants—have shown promise in experimental models. Supportive care, including renal replacement therapy for AKI and inotropic support for cardiac dysfunction, remains essential. Early recognition and aggressive management of contributing factors, such as sepsis or drug toxicity, are critical for improving outcomes.

Recent Advances / Emerging Therapies

Recent advances in molecular pharmacology have led to the development of selective MCU modulators and agents targeting mitochondrial dynamics. Preclinical studies demonstrate that these compounds can attenuate mitochondrial Ca²⁺ overload, reduce oxidative stress, and preserve cellular viability during perioperative organ injury. N-acetylcysteine, melatonin, and mitochondrial-targeted antioxidants (e.g., MitoQ) are under investigation in early clinical trials. Gene editing approaches to modulate expression of MCU complex components offer a potential avenue for personalized interventions in high-risk populations. Additionally, perioperative protocols incorporating remote ischemic preconditioning and optimal glycemic control have been shown to modulate mitochondrial responses and reduce organ injury rates.

Guideline Recommendations

Current perioperative guidelines emphasize risk stratification, intraoperative hemodynamic optimization, minimization of nephrotoxic and cardiotoxic exposures, and early detection of organ dysfunction. The European Society of Anaesthesiology and Intensive Care and the American Heart Association recommend rigorous perioperative monitoring in high-risk patients and the use of evidence-based bundles for organ protection. While specific therapies targeting mitochondrial calcium dysregulation are not yet standard of care, ongoing research is anticipated to inform future guidelines. Multidisciplinary perioperative teams are pivotal in implementing preventive and therapeutic strategies tailored to individual patient risk profiles.

Conclusion

Mitochondrial calcium dysregulation is increasingly recognized as a central mechanism underlying perioperative organ injury. Advances in basic and translational research have elucidated the pathophysiological role of mitochondrial Ca²⁺ overload in mediating cellular dysfunction and organ failure. Risk stratification, early diagnosis, and optimization of perioperative management remain foundational. Although targeted therapies are still under investigation, integrating mechanistic insights into clinical practice holds promise for improving perioperative outcomes. Continued research and multidisciplinary collaboration are essential to translate emerging evidence into effective, personalized strategies for prevention and management of perioperative organ injury.